Seeking collaboration- Monoclonal antibodies for -Filo-, Nairo-, Phenui-, Picorna- and Toga Horizon-HLTH-2027-01-DISEASE-07

R-Evolution Worldwide supports partners build strong international consortia, identify expertise and develop competitive proposals aligned with call requirements and tight deadlines. Experienced in EU-funded European and Euro-African projects, R-EvoWW provides hands-on support from proposal development and submission through implementation, reporting and compliance, while fostering an efficient, collaborative and stimulating working environment.

What we offer:

- EU-funded project development, financial management and reporting

- Dissemination, communication and exploitation activities

- International consortium building and project coordination

What we are looking for:

- Research groups, biotech companies and SMEs developing existing prophylactic or therapeutic monoclonal antibody candidates against virus in scope with the call.

-Preclinical research facilities with suitable animal models for in-vivo efficacy and protection studies

-Expertise in Antibody-Dependent Enhancement (ADE) risk assessment

-GMP manufacturing capabilities for monoclonal antibodies

-Clinical research centres experienced in first-in-human safety studies and early-phase clinical trials

-Regulatory affairs expertise supporting clinical development and marketing authorisation pathways